Effect of Fluoroquinolone Resistance on 14-day Levofloxacin Triple and Triple Plus Bismuth Quadruple Therapy

Lignende værker

• Empiric H. pylori therapy—10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best
  af: Yamaoka, Yoshio, et al.
  Udgivet: (2016)
• Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen
  af: Kahramanoğlu Aksoy, Evrim, et al.
  Udgivet: (2018)
• Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
  af: Lee, Seong tae, et al.
  Udgivet: (2015)
• Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori
  af: Seyyedmajidi, Mohamadreza, et al.
  Udgivet: (2019)
• Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication
  af: Gao, Xiao-Zhong, et al.
  Udgivet: (2010)